Bharat Biotech announces Phase III results of COVAXIN
Bharat Biotech has announced the first interim analysis of its BBV152 (COVAXIN). The whole virion inactivated COVID-19 vaccine…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Algel-IMDG
COVAXIN to boost immune response, longer-lasting immunity with ViroVax’s adjuvant
Bharat Biotech has announced its novel coronavirus vaccine COVAXIN approved for human trials, will use adjuvant Alhydroxiquim-II…